Related references
Note: Only part of the references are listed.Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system
Zhirui Guo et al.
NEUROSCIENCE LETTERS (2016)
CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)
Sandra Motas et al.
JCI INSIGHT (2016)
Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study
Mieke Aldenhoven et al.
BLOOD (2015)
Neuroinflammation, mitochondrial defects and neurodegeneration in mucopolysaccharidosis III type C mouse model
Carla Martins et al.
BRAIN (2015)
Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome)
Rachel A. Mumford et al.
JOURNAL OF NEURODEVELOPMENTAL DISORDERS (2015)
Quantifying behaviors of children with Sanfilippo syndrome: The Sanfilippo Behavior Rating Scale
Elsa G. Shapiro et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells
Luning Jiang et al.
NEUROBIOLOGY OF DISEASE (2015)
PHENOTYPIC EFFECTS OF MATERNAL IMMUNE ACTIVATION AND EARLY POSTNATAL MILIEU IN MICE MUTANT FOR THE SCHIZOPHRENIA RISK GENE NEUREGULIN-1
C. O'Leary et al.
NEUROSCIENCE (2014)
Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning
Jaap Jan Boelens et al.
BLOOD (2013)
Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders
E. M. Cross et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II
Takashi Higuchi et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Hyperactive behaviour in the mouse model of mucopolysaccharidosis IIIB in the open field and home cage environments
A. Langford-Smith et al.
GENES BRAIN AND BEHAVIOR (2011)
Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
Joseph Muenzer et al.
GENETICS IN MEDICINE (2011)
Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test
Alex Langford-Smith et al.
PLOS ONE (2011)
Natural Progression of Neurological Disease in Mucopolysaccharidosis Type II
Joshua B. Holt et al.
PEDIATRICS (2011)
Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB
Maria M. Canal et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy
Vinicia Assunta Polito et al.
HUMAN MOLECULAR GENETICS (2010)
Alterations in Oxidative Markers in the Cerebellum and Peripheral Organs in MPS I Mice
Gustavo Kellermann Reolon et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2009)
Improved Metabolic Correction in Patients with Lysosomal Storage Disease Treated with Hematopoietic Stem Cell Transplant Compared with Enzyme Replacement Therapy
Robert F. Wynn et al.
JOURNAL OF PEDIATRICS (2009)
Bone Marrow Transplantation in Children with Hunter Syndrome: Outcome after 7 to 17 Years
Nathalie Guffon et al.
JOURNAL OF PEDIATRICS (2009)
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
J. Edmond Wraith et al.
EUROPEAN JOURNAL OF PEDIATRICS (2008)
Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome)
Christine Eng et al.
MOLECULAR GENETICS AND METABOLISM (2007)
The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome)
A. R. Garcia et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Phenotypic characterization of spatial cognition and social behavior in mice with 'knockout' of the schizophrenia risk gene neuregulin 1
C. M. P. O'Tuathaigh et al.
NEUROSCIENCE (2007)
Modeling madness in mice: One piece at a time
P. Alexander Arguello et al.
NEURON (2006)
A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)
Joseph Muenzer et al.
GENETICS IN MEDICINE (2006)
Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene delivery
M Cardone et al.
HUMAN MOLECULAR GENETICS (2006)
Cumulative incidence rates of the mucopolysaccharidoses in Germany
F Baehner et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Working memory deficits in retinoid X receptor γ-deficient mice
M Wietrzych et al.
LEARNING & MEMORY (2005)
Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder
DA Brooks et al.
TRENDS IN MOLECULAR MEDICINE (2003)
Differences among eight inbred strains of mice in motor ability and motor learning on a rotorod
MP McFadyen et al.
GENES BRAIN AND BEHAVIOR (2003)
Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory
PM Wall et al.
PSYCHOPHARMACOLOGY (2002)
Enzyme replacement therapy in feline mucopolysaccharidosis I
ED Kakkis et al.
MOLECULAR GENETICS AND METABOLISM (2001)
Share Paper
